Fundai

Atra Zist Arai Company (DATERA) income statement

Operating revenue through to net profit and earnings per share

Ticker
DATERA
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31
Operating revenue8,670,2012,619,3391,790,283
Cost of operating revenue-1,979,725-771,419-669,282
Gross profit (loss)6,690,4761,847,9201,121,001
Selling, general and administrative expenses-859,754-329,223-249,016
Other expenses-193,331-153,786-13,508
Operating profit (loss)5,637,3911,364,911858,477
Finance costs-290,883-160,918-3,107
Other non-operating income and expenses14,4104,61110,413
Profit (loss) from continuing operations before tax5,360,9181,208,604865,783
Current year tax-1,340,230-171,936-172,907
Net profit (loss) from continuing operations4,020,6881,036,668692,876
Net profit (loss)4,020,6881,036,668692,876
Basic earnings (loss) per share1,018 rials262 rials0 rials
Net earnings (loss) per share, rials700 rials263 rials347 rials
Capital5,745,0003,950,9342,000,000

Reporting periods

18 periods are on file for this report, from the period ending 1399/12/30 to the period ending 1405/06/31.